Literature DB >> 31852563

Power to the People: Power, Negative Results and Sample Size.

Brianna N Gaskill, Joseph P Garner.   

Abstract

The practical application of statistical power is becoming an increasingly important part of experimental design, data analysis, and reporting. Power is essential to estimating sample size as part of planning studies and obtaining ethical approval for them. Furthermore, power is essential for publishing and interpreting negative results. In this manuscript, we review what power is, how it can be calculated, and reporting recommendations if a null result is found. Power can be thought of as reflecting the signal to noise ratio of an experiment. The conventional wisdom that statistical power is driven by sample size (which increases the signal in the data), while true, is a misleading oversimplification. Relatively little discussion covers the use of experimental designs which control and reduce noise. Even small improvements in experimental design can achieve high power at much lower sample sizes than (for instance) a simple t test. Failure to report experimental design or the proposed statistical test on animal care and use protocols creates a dilemma for IACUCs, because it is unknown whether sample size has been correctly calculated. Traditional power calculations, which are primarily provided for animal number justifications, are only available for simple, yet low powered, experimental designs, such as paired t tests. Thus, in most controlled experimental studies, the only analyses for which power can be calculated are those that inheriently have low statistical power; these analyses should not be used because they require more animals than necessary. We provide suggestions for more powerful experimental designs (such as randomized block and factorial designs) that increase power, and we describe methods to easily calculate sample size for these designs that are suitable for IACUC number justifications. Finally we also provide recommendations for reporting negative results, so that readers and reviewers can determine whether an experiment had sufficient power. The use of more sophisticated designs in animal experiments will inevitably improve power, reproducibility, and reduce animal use.

Entities:  

Year:  2019        PMID: 31852563      PMCID: PMC6978577          DOI: 10.30802/AALAS-JAALAS-19-000042

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  34 in total

1.  Drug development: Raise standards for preclinical cancer research.

Authors:  C Glenn Begley; Lee M Ellis
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

2.  Romance, risk, and replication: Can consumer choices and risk-taking be primed by mating motives?

Authors:  David R Shanks; Miguel A Vadillo; Benjamin Riedel; Ashley Clymo; Sinita Govind; Nisha Hickin; Amanda J F Tamman; Lara M C Puhlmann
Journal:  J Exp Psychol Gen       Date:  2015-10-26

3.  Caution regarding the use of pilot studies to guide power calculations for study proposals.

Authors:  Helena Chmura Kraemer; Jim Mintz; Art Noda; Jared Tinklenberg; Jerome A Yesavage
Journal:  Arch Gen Psychiatry       Date:  2006-05

4.  Using Effect Size-or Why the P Value Is Not Enough.

Authors:  Gail M Sullivan; Richard Feinn
Journal:  J Grad Med Educ       Date:  2012-09

5.  Six red flags for suspect work.

Authors:  C Glenn Begley
Journal:  Nature       Date:  2013-05-23       Impact factor: 49.962

Review 6.  Refinement of experimental design and conduct in laboratory animal research.

Authors:  Jeremy D Bailoo; Thomas S Reichlin; Hanno Würbel
Journal:  ILAR J       Date:  2014

7.  Publication of Negative Data Contributes to Sound Science.

Authors:  Linda A Toth; Nicole E Duffee
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-09-01       Impact factor: 1.232

8.  The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results.

Authors:  S N Goodman; J A Berlin
Journal:  Ann Intern Med       Date:  1994-08-01       Impact factor: 25.391

9.  A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.

Authors:  Karen J Parker; Ozge Oztan; Robin A Libove; Noreen Mohsin; Debra S Karhson; Raena D Sumiyoshi; Jacqueline E Summers; Kyle E Hinman; Kara S Motonaga; Jennifer M Phillips; Dean S Carson; Lawrence K Fung; Joseph P Garner; Antonio Y Hardan
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

10.  ENU mutagenesis reveals that Notchless homolog 1 (Drosophila) affects Cdkn1a and several members of the Wnt pathway during murine pre-implantation development.

Authors:  Amy C Lossie; Chiao-Ling Lo; Katherine M Baumgarner; Melissa J Cramer; Joseph P Garner; Monica J Justice
Journal:  BMC Genet       Date:  2012-12-12       Impact factor: 2.797

View more
  13 in total

1.  Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder.

Authors:  Ozge Oztan; Joseph P Garner; John N Constantino; Karen J Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-27       Impact factor: 11.205

2.  Small sensory spinal lesions that affect hand function in monkeys greatly alter primary afferent and motor neuron connections in the cord.

Authors:  Karen M Fisher; Joseph P Garner; Corinna Darian-Smith
Journal:  J Comp Neurol       Date:  2022-08-16       Impact factor: 3.028

3.  PU.1 inhibition does not attenuate cardiac function deterioration or fibrosis in a murine model of myocardial infarction.

Authors:  Yibing Nong; Yiru Guo; Qinghui Ou; Anna Gumpert; Alex Tomlin; Xiaoping Zhu; Roberto Bolli
Journal:  Mol Cell Biochem       Date:  2022-09-17       Impact factor: 3.842

4.  Serotonin disruption at gestation alters expression of genes associated with serotonin synthesis and reuptake at weaning.

Authors:  M C Fabio; I J C Servin-Bernal; A L Degano; R M Pautassi
Journal:  Psychopharmacology (Berl)       Date:  2022-09-05       Impact factor: 4.415

5.  Transient serotonin depletion at adolescence, but not at early infancy, reduced subsequent anxiety-like behavior and alcohol intake in female mice.

Authors:  Fabio Bellia; Andrea Suarez; Claudio D'Addario; Ricardo Marcos Pautassi; María Carolina Fabio
Journal:  Psychopharmacology (Berl)       Date:  2020-10-04       Impact factor: 4.530

6.  Assessment of medical morbidities in a rhesus monkey model of naturally occurring low sociality.

Authors:  Adam K Myers; Catherine F Talbot; Laura A Del Rosso; Alyssa C Maness; Sierra M V Simmons; Joseph P Garner; John P Capitanio; Karen J Parker
Journal:  Autism Res       Date:  2021-04-12       Impact factor: 5.216

7.  Mycoplasma pneumoniae Genotypes and Clinical Outcome in Children.

Authors:  Christoph Berger; Roger Dumke; Patrick M Meyer Sauteur; Elena Pánisová; Michelle Seiler; Martin Theiler
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

8.  Full closed loop open-source algorithm performance comparison in pigs with diabetes.

Authors:  Rayhan A Lal; Caitlin L Maikawa; Dana Lewis; Sam W Baker; Anton A A Smith; Gillie A Roth; Emily C Gale; Lyndsay M Stapleton; Joseph L Mann; Anthony C Yu; Santiago Correa; Abigail K Grosskopf; Celine S Liong; Catherine M Meis; Doreen Chan; Joseph P Garner; David M Maahs; Bruce A Buckingham; Eric A Appel
Journal:  Clin Transl Med       Date:  2021-04

9.  Autism-associated biomarkers: test-retest reliability and relationship to quantitative social trait variation in rhesus monkeys.

Authors:  Ozge Oztan; Catherine F Talbot; Emanuela Argilli; Alyssa C Maness; Sierra M Simmons; Noreen Mohsin; Laura A Del Rosso; Joseph P Garner; Elliott H Sherr; John P Capitanio; Karen J Parker
Journal:  Mol Autism       Date:  2021-07-08       Impact factor: 6.476

10.  The epidemiology of fighting in group-housed laboratory mice.

Authors:  Jacob H Theil; Jamie Ahloy-Dallaire; Elin M Weber; Brianna N Gaskill; Kathleen R Pritchett-Corning; Stephen A Felt; Joseph P Garner
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.